Cost-Effectiveness of Therapies for Patients With Nonvalvular Atrial Fibrillation

Archives of Internal Medicine

doi 10.1001/archinte.158.15.1669

Full Text

Abstract

Available in

Date

Authors

Publisher

American Medical Association (AMA)

Related search

Cost-Effectiveness Analysis of Apixaban Against Warfarin for Stroke Prevention in Patients With Nonvalvular Atrial Fibrillation in Japan

Clinical Therapeutics
Pharmacology
2015English

Cost-Effectiveness of Dabigatran (150 Mg Twice Daily) and Warfarin in Patients ≥65 Years With Nonvalvular Atrial Fibrillation

American Journal of Cardiology
Cardiovascular MedicineCardiology
2016English

Platelet Activation in Patients With Chronic Nonvalvular Atrial Fibrillation

International Heart Journal
MedicineCardiovascular MedicineCardiology
2006English

Cost-Effectiveness of New Oral Anticoagulants for Patients With Atrial Fibrillation – A Decision Analysis

Value in Health
MedicineHealth PolicyPublic HealthOccupational HealthEnvironmental
2013English

Risk Stratification of Nonvalvular Atrial Fibrillation

Clinical and Applied Thrombosis/Hemostasis
MedicineHematology
2013English

Potential of Machine Learning Methods to Identify Patients With Nonvalvular Atrial Fibrillation

Future Cardiology
Molecular MedicineCardiovascular MedicineCardiology
2020English

Underuse of Oral Anticoagulants in Patients With Nonvalvular Atrial Fibrillation in Italy

Internal and Emergency Medicine
Internal MedicineEmergency Medicine
2007English

Novel Models for the Prediction of Left Atrial Appendage Thrombus in Patients With Chronic Nonvalvular Atrial Fibrillation

Cardiology Research and Practice
Cardiovascular MedicineCardiology
2019English

Personalizing Bridging Anticoagulation in Patients With Nonvalvular Atrial Fibrillation—a Microsimulation Analysis

Journal of General Internal Medicine
Internal Medicine
2017English

Amanote Research

Note-taking for researchers

Follow Amanote

© 2026 Amaplex Software S.P.R.L. All rights reserved.

Privacy PolicyRefund Policy